MK-677 25 mg — 60 research capsules. MK-677 (Ibutamoren) is the most clinically characterized non-peptidic ghrelin-receptor agonist in the world: the molecule has progressed through more than two dozen Phase I–III trials in healthy adults, the elderly, GH-deficient adults and post-hip-fracture patients. It produces a sustained, physiological pulse-pattern elevation of growth hormone and IGF-1 from a single daily oral dose — without injection, without requiring exogenous GH, and without disrupting the natural circadian secretion architecture. The 25 mg dose corresponds to the most extensively studied tier in published clinical pharmacology.
Research Overview
MK-677 (Ibutamoren) is an orally active, non-peptidic mimetic of the natural GH secretagogue ghrelin, binding selectively to GHS-R1a in the pituitary and hypothalamus [1,2]. It is by far the most extensively characterized molecule in its class. In a landmark two-year placebo-controlled trial in healthy elderly adults, daily oral 25 mg restored serum IGF-1 to the levels of healthy young adults, increased lean body mass by 1.1 kg, preserved bone mineral density, and improved deep slow-wave sleep duration — all while preserving the physiological pulsatile architecture of GH secretion that is disrupted by recombinant GH injection [2]. MK-677 has also been investigated in fall-prone elderly patients post-hip-fracture (functional outcome benefits, reduced fall recurrence), in obese subjects (favorable changes in fat-free mass), and in pediatric GHD where it produced linear growth-velocity acceleration [1–3]. Across thousands of patient-years, the molecule has exhibited a benign tolerability profile, with mild fluid retention and transient appetite stimulation as the principal observations.
Primary Research Areas
- GH / IGF-1 axis pharmacology: the gold-standard probe for studying physiological pulsatile growth hormone release driven by ghrelin-receptor agonism, distinguished from suprapulsatile exogenous GH [1,2].
- Body composition, lean mass and bone: robust evidence of fat-free-mass accretion and BMD preservation in healthy elderly, GH-deficient and post-fracture cohorts, including a two-year RCT [2].
- Sleep architecture and recovery research: documented increases in REM and stage-IV slow-wave-sleep duration, of interest in research on age-related sleep fragmentation [3].
- Sarcopenia, frailty and post-injury recovery: Phase II evidence of functional benefit and reduced fall recurrence in elderly post-hip-fracture cohorts [3].
- Pediatric GH deficiency and metabolic models: evaluated for linear-growth response in GHD children and for metabolic-flexibility endpoints in adult populations [1].
References
- Murphy MG, Plunkett LM, Gertz BJ, et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83(2):320–325.
- Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149(9):601–611.
- Bach MA, Rockwood K, Zetterberg C, et al. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. J Am Geriatr Soc. 2004;52(4):516–523.
- Ghrelin Mimicry: It binds to ghrelin receptors in the hypothalamus and pituitary gland, simulating the effects of the “hunger hormone”.
- Hormone Pulse: It triggers a sustained release of growth hormone without spiking cortisol.
- Oral Bioavailability: Unlike traditional peptide therapies that require injections, MK-677 is a small molecule that can be taken as a pill. [1, 2, 3, 4, 5]
- Regulatory Status: It is an unapproved investigational drug, not an approved dietary supplement or medication. Major health and sports bodies (including the World Anti-Doping Agency) strictly prohibit it. [1, 2, 3, 4]
- Side Effects: Common issues include significant water retention, joint pain, numbness, increased appetite, and elevated blood glucose levels. [1, 2, 3]
- Risks: It can reduce insulin sensitivity, raise the risk of type 2 diabetes or metabolic issues, and has raised cardiac safety concerns in clinical observations. [1, 2, 3]
Why Limitless Biochem?
Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.
- Peptides, Nootropics, Amino acids…
- Products tested by an independent laboratory
- Exclusively pure compounds without additives
- Worldwide Delivery
- Warning
This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.





Avis
Il n’y a pas encore d’avis.